SinoMab BioScienceのEPS 1株当たり利益
SinoMab BioScienceのEPS 1株当たり利益 は何ですか。
SinoMab BioScience LimitedのEPS 1株当たり利益 は-0.16です。
EPS 1株当たり利益 の定義は何ですか。
1株当たり利益（EPS) は、当社の1株当たり利益です。それは株式の希釈を考慮に入れ、 過去12ヶ月間にカウントされます。
Earnings per share is the monetary value of earnings per outstanding share of common stock for a company. Preferred stock rights have precedence over common stock. Therefore, dividends on preferred shares are subtracted before calculating the EPS. When preferred shares are cumulative, annual dividends are deducted whether or not they have been declared. Dividends in arrears are not relevant when calculating EPS. The EPS is usually calculated as profit without preferred dividends divided by weighted average of common stock shares over the past twelve months.
HKSEのセクタHealth CareにおけるEPS 1株当たり利益 の企業と比べるSinoMab BioScience
SinoMab BioScienceは何をしますか。
SinoMab BioScience Limited, a biopharmaceutical company, engages in the research, development, manufacture, and commercialization of therapeutics for the treatment of immunological diseases, primarily monoclonal antibody (mAb)-based biologics. Its flagship product is SM03, a first-in-target anti-CD22 mAb, which is in Phase III clinical trial for the treatment of rheumatoid arthritis (RA), as well as in various clinical stages for other immunological diseases, such as systemic lupus erythematosus (SLE), Sjogren's syndrome (SS), and non-Hodgkin's lymphoma (NHL). The company also focuses on developing SN1011, a Bruton's tyrosine kinase inhibitor, which is Phase I clinical trial for the treatment of RA, SLE, pemphigus, multiple sclerosis, and other immunological diseases. Its products under preclinical stage comprise SM17 for the treatment of asthma and idiopathic pulmonary fibrosis; SM09 that is used for the treatment of NHL and RA; SM06 for use in treating RA, SLE, and SS; and TNF2 for the treatment of RA. The company operates in Mainland China, the Cayman Islands, and Hong Kong. SinoMab BioScience Limited was incorporated in 2001 and is headquartered in Pak Shek Kok, Hong Kong.
SinoMab BioScienceと類似のeps 1株当たり利益
- Taizhou Water CoのEPS 1株当たり利益 は-0.16です。
- Jiangsu Jingyuan Environmental Protection CoのEPS 1株当たり利益 は-0.16です。
- Venus Medtech (Hangzhou) IncのEPS 1株当たり利益 は-0.16です。
- Hive Blockchain TechnologiesのEPS 1株当たり利益 は-0.16です。
- HonworldのEPS 1株当たり利益 は-0.16です。
- TUS InternationalのEPS 1株当たり利益 は-0.16です。
- SinoMab BioScienceのEPS 1株当たり利益 は-0.16です。
- Emerita ResourcesのEPS 1株当たり利益 は-0.16です。
- Tiziana Life Sciences PlcのEPS 1株当たり利益 は-0.16です。
- InterbitのEPS 1株当たり利益 は-0.16です。
- AccurayのEPS 1株当たり利益 は-0.15です。
- MercatorのEPS 1株当たり利益 は-0.15です。
- Century City InternationalのEPS 1株当たり利益 は-0.15です。